Skip to main content
. 2017 Sep 15;9:145–154. doi: 10.1016/j.omtn.2017.09.005

Table 1.

Characteristics of Patients with NSCLC

Variable Number of Patients (%)
p Value
miR124-Low (n = 99) miR124-High (n = 96)
Gender

Male 66 (66.67) 76 (79.17) 0.55
Female 33 (33.33) 20 (20.83)

Age

≤60 49 (49.49) 54 (56.25) 0.35
>60 50 (50.51) 42 (43.75)

Smokinga

Yes 84 (84.85) 8 (8.33) <0.01
No 15 (15.15) 88 (91.67)

Histology

Adenocarcinoma 45 (45.45) 54 (56.25) 0.68
Squamous cell carcinoma 31 (31.31) 22 (22.93)
Bronchioloalveolar carcinoma 15 (15.15) 14 (14.58)
Large-cell carcinoma 5 (5.05) 2 (2.08)
Mucinous adenocarcinoma 1 (3.04) 1 (1.04)
Adenosquamous carcinoma 1 (1.01) 2 (2.08)
Carcinoid 1 (1.01) 1 (1.04)

Histologic Grade

Well differentiated 12 (12.12) 14 (14.58) 0.71
Moderately differentiated 39 (39.39) 42 (43.75)
Poorly differentiated 46 (46.46) 37 (38.54)
Undifferentiated 2 (2.03) 3 (3.13)

T Status

T1 23 (23.23) 28 (29.17) 0.01
T2 12 (12.12) 25 (26.04)
T3 45 (45.45) 36 (37.50)
T4 19 (19.20) 7 (7.29)

N Status

N0 31 (31.31) 65 (67.71) <0.01
N1 26 (26.26) 14 (14.58)
N2 30 (30.30) 12 (12.50)
N3 12 (12.13) 5 (5.21)

M Status

M0 72 (72.73) 69 (71.88) 0.04
M1a 17 (17.17) 8 (8.33)
M1b 10 (10.10) 19 (19.79)
a

Smoker, patients who smoked than one more year and were currently smokers when diagnosed with lung cancer; non-smoker, patients who never smoked.